1-7 of 7
Aaron C. Logan, MDPhDMPhil
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hypomethylating Agents in Combination with Venetoclax As a Bridge to Allogeneic Transplant in Acute Myeloid Leukemia

Vanessa E Kennedy, MD, Gavin Hui, MD, Daria Gaut, MD, Varun Mittal, MD, Caspian Oliai, MD, Lori S. Muffly, MD MS, Aaron C. Logan, MDPhDMPhil, Gabriel N. Mannis, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-143002
Published: 2020
Journal Articles

Excellent Outcomes Achieved with Medical Management of Chronic Phase CML Patients with Non-Hematologic TKI Intolerance

Kelly L. Schoenbeck, MD, Sirisha Tummala, MD, Rebecca L. Olin, MD, Neha G. Goyal, PhD, Anand Dhruva, MD, Lloyd E. Damon, MD, Aaron C. Logan, MDPhDMPhil, Catherine C. Smith, MD, Neil P. Shah, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 41–42.
https://doi.org/10.1182/blood-2020-143303
Published: 2020
Journal Articles

The Discover Trial: Application of the Karius Plasma Next-Generation Sequencing Test for Pathogen Detection in Allogeneic Stem-Cell Transplant Patients

Monica Fung, MD, Hon Seng, BS, Desiree Hollemon, MSN, MPH, David Hong, MD, Timothy Blauwkamp, PhD, Mickey Kertesz, PhD, Jamie Eng, BS, Kathy Wong, BS, Aaron C. Logan, MDPhDMPhil, Peter Chin-Hong, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1937.
https://doi.org/10.1182/blood.V130.Suppl_1.1937.1937
Published: 2017
Journal Articles

The Role of Comprehensive Mutational Profiling in Predicting Patients Who May Benefit from Autologous Hematopoietic Cell Transplant for Acute Myeloid Leukemia

Gabriel N. Mannis, MD, Nicole Therrien, Jessica Van Ziffle, Nicole Foley, Iwei Yeh, Shan Zhong, PhD, Jie He, PhD, Michelle Nahas, PhD, Charalambos Andreadis, MD MSCE, Lloyd E. Damon, MD, Rebecca L. Olin, MD MS, Sonam Prakash, MD, Tariq I Mughal, MD FRCP, Aaron C. Logan, MDPhDMPhil, Thomas G. Martin, III, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1423.
https://doi.org/10.1182/blood.V130.Suppl_1.1423.1423
Published: 2017
Journal Articles

Impact of Demographic and Socioeconomic Factors on Outcomes Following Allogeneic Hematopoietic Cell Transplantation

Nicole Foley, Jimmy Hwang, PhD, Nina Balsamo, MSW, Lia Akhilanda, MSW, Lloyd E. Damon, MD, Rebecca L. Olin, MD MS, Gabriel N. Mannis, MD, Aaron C. Logan, MDPhDMPhil
Journal: Blood
Blood (2017) 130 (Supplement 1): 4570.
https://doi.org/10.1182/blood.V130.Suppl_1.4570.4570
Published: 2017
Journal Articles

Ibrutinib Inhibits cGVHD Pathogenic Pre-Germinal Center B-Cells and Follicular Helper Cells While Preserving Immune Memory and Th1 T-Cells

Bita Sahaf, PhD, Dmitry Tebaykin, PhD, Melissa Hopper, MS, Patricia Cheung, PhD, Fabiola Bittencourt, PhD, Corey S. Cutler, MD MPH, Mukta Arora, MD, Edmund K. Waller, MD, Madan Jagasia, MD MBBS, MS, Iskra Pusic, MD, Mary E. Flowers, MD, Aaron C. Logan, MDPhDMPhil, Samantha Jaglowski, MD MPH, Jason Lih, PhD, Isabelle Solman, MS, Indu D. Lal, MD, Lori Styles, MD, John S. Hill, PhD, Danelle F. James, MD MAS, Sean Bendall, PhD, David B. Miklos, MD PhD, Jason Dubovsky, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4481.
https://doi.org/10.1182/blood.V130.Suppl_1.4481.4481
Published: 2017
Journal Articles

A Phase 1 Trial of the Combination of Ibrutinib and Azacitidine for the Treatment of Higher Risk Myelodysplastic Syndromes: University of California Hematologic Malignancies Consortium (UCHMC) Study 1503

Brian A Jonas, MD PhD, Aaron C. Logan, MDPhDMPhil, Deepa Jeyakumar, MD, Mehrdad Abedi, MD, Rafael Bejar, MD PhD, Matthew J. Wieduwilt, Leslie G. Oesterich, MD, Peter T. Curtin, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2973.
https://doi.org/10.1182/blood.V130.Suppl_1.2973.2973
Published: 2017